New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
14:19 EDTCTRX, CICatamaran weakness a buying opportunity, says Cowen
Cowen attributes the weakness in shares of Catamaran (CTRX) to concerns over the company's relationship with Cigna (CI) should Cigna decide to keep its PBM. Cowen always expected Cigna to keep its PBM, and thinks the market is incorrectly assuming that Cigna's relationship with Catamaran will dissolve if that were to be the case. Cowen thinks the market is misunderstanding the services that Catamaran currently provides to Cigna and recommends buying the stock on today's pullback.
News For CTRX;CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2015
12:39 EDTCICigna May June volatility elevated
Cigna June call option implied volatility is at 29, July is at 26, October is at 27; compared to its 52 week range of 16 to 31, suggesting large near term price movement.
May 19, 2015
12:04 EDTCIAnthem CFO says 'good time' for 'meaningful' acquisition, Reuters reports
Subscribe for More Information
May 18, 2015
10:47 EDTCTRXOptions with increasing implied volatility: KNDI CTRX
Subscribe for More Information
May 15, 2015
10:34 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
May 14, 2015
11:06 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
May 13, 2015
11:22 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
10:18 EDTCIAnalyst says sell Humana amid 'wishful' takeover speculation
Subscribe for More Information
06:12 EDTCIHumana downgraded to Underperform from Neutral at Sterne Agee CRT
Sterne Agee CRT analyst Brian Wright downgraded Humana (HUM) to Underperform saying speculation about a takeover is "wishful thinking" at current share levels. The stock rallied 4% yesterday after Leerink told investors that Aetna (AET) may acquire Humana or Cigna (CI) in the near-term. Wright also sees "material" risk to Humana's earnings guidance risk with paid claims outpacing premium growth. He lowered his price target for shares to $150 from $165. Humana shares closed yesterday up $6.76 to $173.38.
May 12, 2015
15:39 EDTCICigna May volatility elevated
Cigna May call option implied volatility is at 35, June is at 28, and August is at 30; compared to its 90-day average of 31, suggesting large near term price movement.
11:53 EDTCIAnalyst predicts large transaction 'imminent' for Aetna
Subscribe for More Information
10:28 EDTCTRXOptions with increasing implied volatility: YELP HUM LULU CTRX
Subscribe for More Information
May 11, 2015
07:40 EDTCTRXFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use